Abeona Therapeutics (ABEO) vs Vogenx (VOGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Abeona Therapeutics is the larger company by market cap ($283.6 million vs $259.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABEO | VOGX |
|---|---|---|
| Share price | $4.96 | $17.49 |
| Market cap | $283.63M | $259.82M |
| 1-day change | -2.36% | +8.23% |
| YTD return | -5.88% | — |
| 1-year return | -10.47% | — |
| 5-year return | -77.67% | — |
| EPS (TTM) | $-1.18 | $-0.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.65 | $38.41 |
| 52-week low | $4.00 | $12.95 |
| Distance from 52-week high | -35.16% | -54.46% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +280.65% | +214.47% |
| Average volume | 1.41M | 187.66K |
| Shares outstanding | 57.18M | 14.86M |
| Employees | 226 | 4 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Abeona Therapeutics
ABEO stock →Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa.
Health Care · Biotechnology: Pharmaceutical Preparations · 226 employees
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
ABEO vs VOGX FAQ
Which is bigger, Abeona Therapeutics or Vogenx?
Abeona Therapeutics (ABEO) is larger, with a market capitalization of $283.63M compared with $259.82M for Vogenx (VOGX).
Are Abeona Therapeutics and Vogenx in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.